These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 26427906)

  • 21. The Structures of eIF4E-eIF4G Complexes Reveal an Extended Interface to Regulate Translation Initiation.
    Grüner S; Peter D; Weber R; Wohlbold L; Chung MY; Weichenrieder O; Valkov E; Igreja C; Izaurralde E
    Mol Cell; 2016 Nov; 64(3):467-479. PubMed ID: 27773676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural scaffold for eIF4E binding selectivity of 4E-BP isoforms: crystal structure of eIF4E binding region of 4E-BP2 and its comparison with that of 4E-BP1.
    Fukuyo A; In Y; Ishida T; Tomoo K
    J Pept Sci; 2011 Sep; 17(9):650-7. PubMed ID: 21661078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A unique binding mode of the eukaryotic translation initiation factor 4E for guiding the design of novel peptide inhibitors.
    Di Marino D; D'Annessa I; Tancredi H; Bagni C; Gallicchio E
    Protein Sci; 2015 Sep; 24(9):1370-82. PubMed ID: 26013047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gating by tryptophan 73 exposes a cryptic pocket at the protein-binding interface of the oncogenic eIF4E protein.
    Lama D; Brown CJ; Lane DP; Verma CS
    Biochemistry; 2015 Oct; 54(42):6535-44. PubMed ID: 26427906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crystallographic and mass spectrometric characterisation of eIF4E with N7-alkylated cap derivatives.
    Brown CJ; McNae I; Fischer PM; Walkinshaw MD
    J Mol Biol; 2007 Sep; 372(1):7-15. PubMed ID: 17631896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-oncogenic potential of the eIF4E-binding proteins.
    Martineau Y; Azar R; Bousquet C; Pyronnet S
    Oncogene; 2013 Feb; 32(6):671-7. PubMed ID: 22508483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eukaryotic translation initiation factor 4E as a novel therapeutic target in hematological malignancies and beyond.
    Pettersson F; Del Rincon SV; Miller WH
    Expert Opin Ther Targets; 2014 Sep; 18(9):1035-48. PubMed ID: 25004955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oncogenic protein interfaces: small molecules, big challenges.
    Nero TL; Morton CJ; Holien JK; Wielens J; Parker MW
    Nat Rev Cancer; 2014 Apr; 14(4):248-62. PubMed ID: 24622521
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 30.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.